Revlimib and multiple myeloma Patient Reports February 09, 2012

Revlimib Side Effects Report #5375788-6
Revlimib side effect was reported by a Physician from UNITED STATES on June 22, 2007. Female patient, 70 years of age, was diagnosed with multiple myeloma  and was treated with Revlimib. After drug was administered, patient experienced the following side effects: malignant neoplasm progression, multiple myeloma . Revlimib dosage: 25 MG, 1 IN 1D, ORAL. Patient died on 04/15/2007.